36 reports

  • GLOBAL ANTIVIRAL DRUGS MARKET SEGMENTATION BY THERAPIES
  • VIRAL DISEASE

About Antiviral Drugs Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow...

  • Influenza
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation
  • 22.1 MALTA SEASONAL INFLUENZA VACCINATED TOTAL POPULATION

In Malta, seasonal influenza vaccination is recommended for all aged ## years and over, children between ## months and ## months old, and persons of any age suffering from chronic diseases of the lungs, heart, liver, kidney, diabetes, and any immunodeficiency conditions, including HIV and

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • 6.1 Malta Seasonal Influenza Vaccinated Total Population

In Malta, seasonal influenza vaccination is recommended for all aged ## years and over, children between ## months and ## months old, and persons of any age suffering from chronic diseases of the lungs, heart, liver, kidney, diabetes, and any immunodeficiency conditions, including HIV and

  • Influenza
  • Vaccine
  • Southern Europe
  • Forecast
  • Market Size
  • Which factors contribute to the severity of seasonal influenza?

Young children and the elderly are the most at risk of severe and/ or fatal influenza, as well as consumers with underlying health conditions, such as heart disease or HIV/ AIDS.

  • Influenza
  • Vaccine
  • United States
  • Demand
  • Mondelez International, Inc.
  • 21.1 MALTA SEASONAL INFLUENZA VACCINATED TOTAL POPULATION

In Malta, seasonal influenza vaccination is recommended for all aged ## years and over, children between ## months and ## months old, and persons of any age suffering from chronic diseases of the lungs, heart, liver, kidney, diabetes, and any immunodeficiency conditions, including HIV and

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Influenza
  • Germany
  • Japan
  • United States
  • Forecast
  • NVINF-2 - DRUG PROFILE

It offers pipeline product portfolio such as drugs for various indications such as HIV, influenza, flaviviruses including dengue and eye drops, among others.

  • Influenza
  • Vaccine
  • United States
  • Company Operations
  • NanoViricides, Inc.
  • NVINF-2 - DRUG PROFILE

It offers pipeline product portfolio such as drugs for various indications such as HIV, influenza, flaviviruses including dengue and eye drops, among others.

  • Influenza
  • United States
  • Company
  • Product Initiative
  • NanoViricides, Inc.

Specifically, malaria, HIV/ AIDS, enteric pathogens, influenza, hemorrhagic fever viruses, and arthropod-borne diseases are among the most important of the militarily-relevant infectious agents.

  • Diagnostics
  • Influenza
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • NVINF-2 - DRUG PROFILE
  • NVINF-2 - DRUG PROFILE

The drug candidate is in Phase-II stage of development for pancreatic cancer in China and U. S and Phase II stage of development for ovarian cancer, hepatocellular carcinoma and HIV/ AIDS and head and neck cancer.

  • Influenza
  • Pathology
  • Vaccine
  • United States
  • Product Initiative
  • PARTNERSHIPS

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Influenza
  • Israel
  • United States
  • Company
  • BiondVax Pharmaceuticals Ltd.
  • NVINF-2 - DRUG PROFILE

It offers pipeline product portfolio such as drugs for various indications such as HIV, influenza, flaviviruses including dengue and eye drops, among others.

  • Influenza
  • Pathology
  • Vaccine
  • United States
  • Product Initiative

GOVERNMENT S INITIATIVE TO DELIVER LIFE-SAVING SERVICES AND IMPROVE THE LIVES OF THOSE LIVING WITH HIV/ AIDS AROUND THE WORLD.

  • Clinical Trial
  • Influenza
  • Interventional Cardiology Device
  • Medical Device
  • Endologix, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • Clinical Trial profile. 1645 Trial Title
  • Clinical Trial profile. 203 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Influenza
  • Vaccine
  • World
  • GlaxoSmithKline plc
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd Microgen Scientific Industrial Company for Immunobiological ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Medicines ## ## ## ## ## ## ## ## Altimmune Inc ## ## ## ## ## ## ## ## CSL Ltd Source: GlobalData' s Pharma Intelligence Center C

  • Drug Discovery And Development
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • NVINF-2 - DRUG PROFILE

Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description NA NA SYNTHETIC PEPTIDES FOR INFLUENZA, HSV AND HIV INFECTIONS - DRUG PROFILE SYNTHETIC PEPTIDES FOR INFLUENZA, HSV AND HIV INFECTIONS UNIVERSITY OF WISCONSIN MADISON SYNTHETIC PEPTI

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.
  • NVINF-2 - DRUG PROFILE

Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description NA NA SYNTHETIC PEPTIDES FOR INFLUENZA, HSV AND HIV INFECTIONS - DRUG PROFILE SYNTHETIC PEPTIDES FOR INFLUENZA, HSV AND HIV INFECTIONS UNIVERSITY OF WISCONSIN MADISON SYNTHETIC PEPTI

  • Influenza
  • United States
  • World
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Influenza
  • Therapy
  • World
  • Product Initiative
  • NVINF-2 - DRUG PROFILE
  • NVINF-2 - DRUG PROFILE

It offers pipeline product portfolio such as drugs for various indications such as HIV, influenza, flaviviruses including dengue and eye drops, among others.

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Infectious Disease
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • NVINF-2 - DRUG PROFILE

THE DRUG CANDIDATE IS IN PHASE-II STAGE OF DEVELOPMENT FOR PANCREATIC CANCER IN CHINA AND U. S AND PHASE II STAGE OF DEVELOPMENT FOR OVARIAN CANCER, HEPATOCELLULAR CARCINOMA AND HIV/ AIDS AND HEAD AND NECK CANCER.

  • Influenza
  • Therapy
  • Vaccine
  • United States
  • Product Initiative

Specifically, malaria, HIV/ AIDS, enteric pathogens, influenza, hemorrhagic fever viruses, and arthropod-borne diseases are among the most important of the militarily-relevant infectious agents.

  • Diagnostics
  • Influenza
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • May 02, 2018: Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Ward is also affiliated with the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center and Center for HIV/ AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) at Scripps Research.

  • Influenza
  • Pharmaceutical
  • Therapy
  • Vaccine
  • United States

RISK FACTORS INCLUDE ASTHMA, NASAL PASSAGE ABNORMALITY, IMMUNE SYSTEM DISORDER, SUCH AS HIV/ AIDS OR CYSTIC FIBROSIS AND ANOTHER ALLERGIC CONDITION.

  • Cough And Cold
  • Influenza
  • Therapy
  • United States
  • Product Initiative
  • Daiichi Sankyo Company, Limited - Dormant Developmental Projects,2016

THE DRUG CANDIDATE BY INHIBITING THE DR## ACTIVITY AIDS IN THE TREATMENT OF UNDERLYING CAUSE.

  • Breast Cancer
  • Influenza
  • Monoclonal Antibody
  • Therapy
  • Daiichi Sankyo Company

It was also under development for the treatment of melanoma, renal cell carcinoma and HIV / AIDS.

  • Influenza
  • United States
  • Company
  • Product Initiative
  • Hemispherx Biopharma, Inc.
  • Clinical Trial Profile Snapshots

## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clin

  • Infectious Disease
  • Influenza
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

## ## ## ## ## ## Mexico ## ## ## ## ## ## Russia ## ## ## ## ## ## Turkey ## ## ## ## ## ## Indonesia ## ## ## ## ## ## Brazil ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are tak

  • Influenza
  • Pathology
  • Therapy
  • World
  • Product Initiative